Airway stent current practices evaluation: Survey among French bronchoscopy practitioners.


Journal

Respiratory medicine and research
ISSN: 2590-0412
Titre abrégé: Respir Med Res
Pays: France
ID NLM: 101746324

Informations de publication

Date de publication:
Mar 2020
Historique:
received: 26 04 2019
revised: 14 01 2020
accepted: 14 02 2020
pubmed: 4 6 2020
medline: 3 6 2021
entrez: 4 6 2020
Statut: ppublish

Résumé

Airway stenting (AS) is performed for the treatment of benign or malignant central airway stenosis. In France, more than 30 centers practice AS. The aim of this survey was to evaluate the current practice around airway stenting among French bronchoscopy practitioners. We performed an online survey sent to the GELF group (Groupe d'Endoscopie de Langue Française) mailing list. The first part comprised 10 questions about the different attitudes before AS and the second part included 10 questions about the management after AS. Thirty-six participants answered to the first part of the questionnaire and thirty-three to the second. There were some similarities, for example the absence of prophylactic antibiotic treatment before procedure (86%), use of saline nebulization, and removing or replacing the airway stent in case of persistent chest congestion or infection (73%). We also noted an important heterogeneity of the practices with several differences concerning systematic endoscopic control, bacteriological sampling before procedure (44%) and systematically AS replacement. This survey shows that AS management in France varies between practitioners. Respondents agreed on a few points, but disagreed on several important aspects of the management. These results emphasize the need of expert recommendations to improve AS management.

Sections du résumé

BACKGROUND BACKGROUND
Airway stenting (AS) is performed for the treatment of benign or malignant central airway stenosis. In France, more than 30 centers practice AS. The aim of this survey was to evaluate the current practice around airway stenting among French bronchoscopy practitioners.
METHOD METHODS
We performed an online survey sent to the GELF group (Groupe d'Endoscopie de Langue Française) mailing list. The first part comprised 10 questions about the different attitudes before AS and the second part included 10 questions about the management after AS.
RESULTS RESULTS
Thirty-six participants answered to the first part of the questionnaire and thirty-three to the second. There were some similarities, for example the absence of prophylactic antibiotic treatment before procedure (86%), use of saline nebulization, and removing or replacing the airway stent in case of persistent chest congestion or infection (73%). We also noted an important heterogeneity of the practices with several differences concerning systematic endoscopic control, bacteriological sampling before procedure (44%) and systematically AS replacement.
CONCLUSION CONCLUSIONS
This survey shows that AS management in France varies between practitioners. Respondents agreed on a few points, but disagreed on several important aspects of the management. These results emphasize the need of expert recommendations to improve AS management.

Identifiants

pubmed: 32492650
pii: S2590-0412(20)30008-8
doi: 10.1016/j.resmer.2020.02.003
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

89-94

Informations de copyright

Copyright © 2020. Published by Elsevier Masson SAS.

Auteurs

E Virot (E)

Respiratory Disease Department, Strasbourg University Hospital, Strasbourg, France. Electronic address: edouard.virot@chru-strasbourg.fr.

C Marcot (C)

Respiratory Disease Department, Strasbourg University Hospital, Strasbourg, France.

J-M Vergnon (JM)

Department of Pulmonology, University Hospital of Saint-Étienne, 42000 Saint-Étienne, France.

C Matau (C)

Respiratory Disease Department, Strasbourg University Hospital, Strasbourg, France.

M Porzio (M)

Respiratory Disease Department, Strasbourg University Hospital, Strasbourg, France.

R Kessler (R)

Respiratory Disease Department, Strasbourg University Hospital, Strasbourg, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH